Novel compounds and pharmaceutical compositions comprising the same as active ingredients
CN122396685APending Publication Date: 2026-07-14SAPIENS BIOTECHNOLOGY CO LTD
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SAPIENS BIOTECHNOLOGY CO LTD
- Filing Date
- 2024-12-12
- Publication Date
- 2026-07-14
Smart Images
Figure CN122396685A_ABST
Abstract
The present invention relates to a novel compound having a fibrosis inhibitory effect. The compound according to the present invention or a pharmaceutically acceptable salt thereof has been confirmed to effectively inhibit the expression (formation) of alpha-SMA, COL1A1, and F-actin, which are main pathogenic factors of fibrosis. Accordingly, the novel compound according to the present invention is expected to be effectively used as a therapeutic agent having a fibrosis reducing or inhibiting effect for the prevention and treatment of fibrosis-related diseases.
Need to check novelty before this filing date? Find Prior Art